Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Priveq Investment in connection with the investment in ROL
Mandate

Vinge has advised Priveq Investment in connection with the investment in ROL

June 16, 2021 Employment and Benefits Banking and Finance Real Estate and Construction Intellectual Property IT, Telecommunications and Outsourcing M&A Environmental Law

Today ROL offers workspace solutions including software and ergonomically optimized office furniture and store concept solutions. ROL’s offering is sold globally both through ROL’s own sales organization and distributors. In 2020, ROL had a turnover of approximately SEK 1.6 billion and 890 employees in ten different countries.

The Hjelm family has partnered with Priveq Investment as a new minority owner to support the company in its accelerated growth strategy. The Hjelm family will continue as majority owners in ROL, with Arne Karlsson continuing as the Chairman of the Board.

Vinge’s team consisted of Jonas Johansson, Karl Klackenberg and Jesper Lindvall (M&A), together with Kristoffer Larson (Real Estate), Johan Cederblad and Lina Österberg (Environment), Jolene Reimerson and Mathilda Persson (IT, Agreements and GDPR), Sofia Bergenstråhle (IP), Karl-Gustaw Tobola (Financing), Ebba Svenburg (Employment), Carl Bruneheim and Viktoria Owetz Leyva (VDR).

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

 Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

 Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026